(ABN) ABN Amro - Ratings and Ratios

Exchange: AS • Country: Netherlands • Currency: EUR • Type: Common Stock • ISIN: NL0011540547

Banking, Financial, Savings, Loans, Insurance, Investments, Cards

ABN EPS (Earnings per Share)

EPS (Earnings per Share) of ABN over the last years for every Quarter: "2020-03": -0.4499999886076, "2020-06": -0.0046511627906977, "2020-09": 0.28, "2020-12": 0.057446808510638, "2021-03": -0.08, "2021-06": 0.38758018622683, "2021-09": 0.34000000991254, "2021-12": 0.55999999188406, "2022-03": 0.2899999941017, "2022-06": 0.4669491430451, "2022-09": 0.81549506477314, "2022-12": 0.39441934508785, "2023-03": 0.58271558610436, "2023-06": 1.0051117441646, "2023-09": 0.87687334921949, "2023-12": 0.6296389661721, "2024-03": 0.76, "2024-06": 0.73, "2024-09": 0.78, "2024-12": 0.43, "2025-03": 0.69, "2025-06": 0.67,

ABN Revenue

Revenue of ABN over the last years for every Quarter: 2020-03: 1947, 2020-06: 1952, 2020-09: 1935, 2020-12: 1825, 2021-03: 1855, 2021-06: 1722, 2021-09: 1725, 2021-12: 1982, 2022-03: 1959, 2022-06: 1904, 2022-09: 2123, 2022-12: 1872, 2023-03: 2166, 2023-06: 2228, 2023-09: 2234, 2023-12: 5168, 2024-03: 2240, 2024-06: 2170, 2024-09: 2273, 2024-12: 2223, 2025-03: 2155, 2025-06: 2143,

Description: ABN ABN Amro

ABN AMRO Bank N.V. is a Dutch banking giant offering a broad spectrum of financial products and services to retail, private, and business clients across multiple geographies, including Europe, the US, and Asia. The bank operates through three main segments: Personal & Business Banking, Wealth Management, and Corporate Banking, providing a diverse range of services including savings accounts, loans, mortgage products, investment products, and various insurance types.

From a financial perspective, ABN AMRO demonstrates a solid performance. With a Market Cap of approximately €20.9 billion, the banks stock trades at a reasonable P/E ratio of 9.66, indicating a relatively undervalued position compared to its earnings. The forward P/E ratio is similarly attractive at 9.58, suggesting that the market expects stable or slightly improving earnings in the future. The Return on Equity (RoE) stands at 8.99%, a respectable figure that indicates the banks ability to generate profits from shareholders equity.

To further evaluate ABN AMROs performance, additional Key Performance Indicators (KPIs) can be considered. For instance, the banks Net Interest Margin (NIM) is a crucial metric, as it reflects the difference between the interest income generated by the bank and the amount of interest paid out to depositors. A stable or increasing NIM would be a positive indicator. Additionally, the banks Capital Adequacy Ratio (CAR) and the Common Equity Tier 1 (CET1) ratio are important metrics to assess its capital strength and resilience to potential financial shocks. A high-quality loan portfolio and a manageable Non-Performing Loan (NPL) ratio are also vital for the banks long-term sustainability.

In terms of growth prospects, ABN AMROs diversified business model across different geographies and segments could provide a stable foundation. The banks exposure to the Dutch market, while significant, is somewhat mitigated by its international presence. The ongoing digital transformation in the banking sector also presents opportunities for ABN AMRO to enhance its online and mobile banking services, potentially attracting more tech-savvy customers and improving operational efficiency.

ABN Stock Overview

Market Cap in USD 25,132m
Sub-Industry Diversified Banks
IPO / Inception

ABN Stock Ratings

Growth Rating 94.8%
Fundamental 50.1%
Dividend Rating 74.7%
Return 12m vs S&P 500 44.0%
Analyst Rating -

ABN Dividends

Dividend Yield 12m 6.24%
Yield on Cost 5y 23.76%
Annual Growth 5y 16.99%
Payout Consistency 93.5%
Payout Ratio 50.2%

ABN Growth Ratios

Growth Correlation 3m 90.3%
Growth Correlation 12m 89.5%
Growth Correlation 5y 94.9%
CAGR 5y 34.61%
CAGR/Max DD 5y 0.92
Sharpe Ratio 12m 1.98
Alpha 60.11
Beta 0.574
Volatility 33.78%
Current Volume 2462.4k
Average Volume 20d 2451.7k
Stop Loss 23.9 (-3%)
Signal 1.47

Piotroski VR‑10 (Strict, 0-10) 2.5

Net Income (2.31b TTM) > 0 and > 6% of Revenue (6% = 527.6m TTM)
FCFTA -0.03 (>2.0%) and ΔFCFTA -2.80pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
error: NWC/Revenue cannot be calculated (needs Current Assets/Liabilities and Revenue current+prev)
CFO/TA -0.03 (>3.0%) and CFO -10.79b <= Net Income 2.31b (YES >=105%, WARN >=100%)
Net Debt (34.21b) to EBITDA (9.41b) ratio: 3.63 <= 3.0 (WARN <= 3.5)
error: Current Ratio cannot be calculated (needs Total Current Assets and Liabilities)
Outstanding Shares last Quarter (833.0m) change vs 12m ago 0.0% (target <= -2.0% for YES)
Gross Margin 100.0% (prev 73.81%; Δ 26.19pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 2.18% (prev 3.00%; Δ -0.82pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 1.33 (EBITDA TTM 9.41b / Interest Expense TTM 7.10b) >= 6 (WARN >= 3)

ValueRay F-Score (Strict, 0-100) 50.10

1. Piotroski 2.50pt = -2.50
2. FCF Yield -40.44% = -5.0
3. FCF Margin data missing
4. Debt/Equity data missing
5. Debt/Ebitda data missing
6. ROIC - WACC 6.10% = 7.62
7. RoE 8.65% = 0.72
8. Rev. Trend 3.58% = 0.18
9. Rev. CAGR 0.34% = 0.04
10. EPS Trend -4.08% = -0.10
11. EPS CAGR -6.90% = -0.86

What is the price of ABN shares?

As of August 31, 2025, the stock is trading at EUR 24.65 with a total of 2,462,384 shares traded.
Over the past week, the price has changed by -4.72%, over one month by -0.82%, over three months by +10.74% and over the past year by +68.39%.

Is ABN Amro a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, ABN Amro is currently (August 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 50.10 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ABN is around 32.19 EUR . This means that ABN is currently undervalued and has a potential upside of +30.59% (Margin of Safety).

Is ABN a buy, sell or hold?

ABN Amro has no consensus analysts rating.

What are the forecasts/targets for the ABN price?

Issuer Target Up/Down from current
Wallstreet Target Price 24 -2.7%
Analysts Target Price - -
ValueRay Target Price 35.8 45.1%

ABN Fundamental Data Overview

Market Cap USD = 25.13b (21.58b EUR * 1.1648 EUR.USD)
Market Cap EUR = 21.58b (21.58b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 49.39b EUR (Cash only, last quarter)
P/E Trailing = 10.0388
P/E Forward = 10.0806
P/S = 2.451
P/B = 0.7851
P/EG = 2.9952
Beta = 0.944
Revenue TTM = 8.79b EUR
EBIT TTM = 9.41b EUR
EBITDA TTM = 9.41b EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = 34.21b EUR (from netDebt column, last quarter)
Enterprise Value = -27.81b EUR (21.58b + (null Debt) - CCE 49.39b)
Interest Coverage Ratio = 1.33 (Ebit TTM 9.41b / Interest Expense TTM 7.10b)
FCF Yield = -40.44% (FCF TTM -11.25b / Enterprise Value -27.81b)
FCF Margin = -127.9% (FCF TTM -11.25b / Revenue TTM 8.79b)
Net Margin = 26.29% (Net Income TTM 2.31b / Revenue TTM 8.79b)
Gross Margin = unknown ((Revenue TTM 8.79b - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = -11.57 (set to none) (Enterprise Value -27.81b / Book Value Of Equity 2.40b)
Interest Expense / Debt = unknown (Interest Expense 2.16b / Debt none)
Taxrate = 29.66% (from yearly Tax Provision: 1.01b / 3.42b)
NOPAT = 6.62b (EBIT 9.41b * (1 - 29.66%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt 34.21b / EBITDA 9.41b)
Debt / FCF = none (Debt none / FCF TTM -11.25b)
Total Stockholder Equity = 26.73b (last 4 quarters mean)
RoA = 0.56% (Net Income 2.31b, Total Assets 413.92b )
RoE = 8.65% (Net Income TTM 2.31b / Total Stockholder Equity 26.73b)
RoCE = unknown (Ebit 9.41b / (Equity 26.73b + L.T.Debt none))
RoIC = 6.10% (NOPAT 6.62b / Invested Capital 108.57b)
WACC = unknown (E(21.58b)/V(0.0) * Re(8.13%)) + (D(none)/V(0.0) * Rd(none%) * (1-Tc(0.30)))
Shares Correlation 5-Years: -30.0 | Cagr: -0.35%
Discount Rate = 8.13% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow -11.25b)
Revenue Correlation: 3.58 | Revenue CAGR: 0.34%
Rev Growth-of-Growth: -36.99
EPS Correlation: -4.08 | EPS CAGR: -6.90%
EPS Growth-of-Growth: -26.71

Additional Sources for ABN Stock

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle